Varonis Systems Class Action Lawsuit Announcement
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Should l Buy VRNS?
Source: Globenewswire
- Class Action Initiation: Robbins Geller law firm announces that investors who purchased Varonis Systems (NASDAQ: VRNS) common stock between February 4, 2025, and October 28, 2025, can apply to be lead plaintiff in the class action lawsuit by March 9, 2026, indicating strong investor concern over the company's financial transparency.
- Allegations: The lawsuit accuses Varonis and its executives of violating the Securities Exchange Act of 1934 by misleading investors regarding financial projections, failing to accurately reflect the sustainability of annual recurring revenue growth, which could lead to significant investor losses.
- Stock Price Plunge: Following the release of third-quarter results on October 28, 2025, which fell well below expectations, Varonis's stock price dropped nearly 49%, reflecting a severe lack of market confidence in the company's future growth potential, potentially impacting its financing capabilities and market position.
- Law Firm Background: Robbins Geller is one of the world's leading complex class action firms, recovering over $916 million for investors in 2025, showcasing its strong capabilities in securities fraud and shareholder rights litigation, which may attract more investors to participate in the lawsuit seeking compensation.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy VRNS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on VRNS
Wall Street analysts forecast VRNS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for VRNS is 52.18 USD with a low forecast of 37.00 USD and a high forecast of 80.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
18 Analyst Rating
14 Buy
4 Hold
0 Sell
Strong Buy
Current: 22.650
Low
37.00
Averages
52.18
High
80.00
Current: 22.650
Low
37.00
Averages
52.18
High
80.00
About VRNS
Varonis Systems, Inc. is a data security company. The Company’s cloud-native data security platform discovers and classifies critical data, removes exposures, and detects advanced threats with artificial intelligence (AI)-powered automation. Varonis software enables enterprises of all sizes and industries to protect data stored in the cloud and on-premises, including sensitive files, emails and databases; confidential personal data belonging to customers, patients and employees; financial records; source code, strategic and product plans; and other intellectual property. Its SaaS product portfolio includes two product lines: its flagship Varonis Data Security Platform, which protects Microsoft 365, Windows file shares, Active Directory, Edge devices (VPN, DNS, proxy), UNIX/Linux and hybrid NAS storage, and DatAdvantage Cloud, which protects IaaS environments and SaaS applications, such as Salesforce, AWS, Azure, Google Cloud, Google Workspace, Databricks, ServiceNow, and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Reminder for Varonis Investors on Class Action Deadline
- Earnings Miss: Varonis reported third-quarter 2025 results that missed expectations, with a 63.9% year-over-year decline in annual subscription revenues, indicating significant challenges in maintaining ARR growth, which could undermine investor confidence moving forward.
- Stock Plunge: Following the disappointing earnings report, Varonis's stock price plummeted by $30.66, or 48.7%, closing at $32.34 per share on October 29, 2025, resulting in substantial losses for investors and reflecting a pessimistic outlook on the company's future.
- Lawsuit Allegations: The class action lawsuit alleges that Varonis failed to disclose material adverse facts regarding its business and prospects during the class period, particularly its inability to sustain ARR growth, which may have misled investors about the company's true performance.
- Legal Action Deadline: Investors must file a lead plaintiff motion by March 9, 2026, to participate in the class action; those who do not act will automatically become absent members, potentially affecting their rights to recover losses.
See More
Reminder of Shareholder Class Action Lawsuits
- Fermi Inc. Lawsuit: The shareholder class action lawsuit against Fermi Inc. alleges that the company failed to disclose significant facts regarding tenant demand for its Project Matador campus between October 1 and December 11, 2025, leading to substantial investor losses, with a deadline of March 6, 2026, to apply as lead plaintiff.
- Ardent Health Case: The class action lawsuit against Ardent Health, Inc. claims that the company did not disclose material facts about the collectability of its accounts receivable from July 18, 2024, to November 12, 2025, and investors must apply by March 9, 2026, if they suffered losses during this period.
- Varonis Systems Lawsuit: The lawsuit against Varonis Systems, Inc. alleges that the company misled investors regarding its ability to convert its customer base and its ARR growth potential from February 4 to October 28, 2025, with a lead plaintiff application deadline of March 9, 2026.
- Law Firm Background: Holzer & Holzer, LLC, rated as a top securities litigation firm by ISS from 2021 to 2025, has been representing shareholders since 2000, recovering hundreds of millions for those affected by corporate misconduct.
See More
Varonis Systems Class Action Lawsuit Announcement
- Class Action Initiation: Robbins Geller law firm announces that investors who purchased Varonis Systems (NASDAQ: VRNS) common stock between February 4, 2025, and October 28, 2025, can apply to be lead plaintiff in the class action lawsuit by March 9, 2026, indicating strong investor concern over the company's financial transparency.
- Allegations: The lawsuit accuses Varonis and its executives of violating the Securities Exchange Act of 1934 by misleading investors regarding financial projections, failing to accurately reflect the sustainability of annual recurring revenue growth, which could lead to significant investor losses.
- Stock Price Plunge: Following the release of third-quarter results on October 28, 2025, which fell well below expectations, Varonis's stock price dropped nearly 49%, reflecting a severe lack of market confidence in the company's future growth potential, potentially impacting its financing capabilities and market position.
- Law Firm Background: Robbins Geller is one of the world's leading complex class action firms, recovering over $916 million for investors in 2025, showcasing its strong capabilities in securities fraud and shareholder rights litigation, which may attract more investors to participate in the lawsuit seeking compensation.
See More
Varonis Systems Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Varonis Systems (NASDAQ: VRNS) common stock between February 4, 2025, and October 28, 2025, to apply as lead plaintiffs by March 9, 2026, to participate in the class action without any out-of-pocket fees.
- Lawsuit Background: The lawsuit alleges that Varonis failed to maintain annual recurring revenue (ARR) projections and could not effectively convince existing customers to transition to the software-as-a-service (SaaS) model, resulting in significantly reduced ARR growth potential and investor losses.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and recovered over $438 million for investors in 2019 alone, being ranked No. 1 by ISS Securities Class Action Services in 2017, showcasing its strong capabilities in this field.
- Investor Guidance: Investors are advised to carefully select counsel with a proven track record to ensure effective representation in the class action, avoiding firms that merely act as intermediaries.
See More
Multiple Companies Face Class Action Lawsuits
- Varonis Systems Lawsuit: During the class period from February 4, 2025, to October 28, 2025, Varonis is accused of failing to sustain its annual recurring revenue growth, which has severely undermined investor confidence in the company's prospects, with a lead plaintiff deadline set for March 9, 2026.
- Ardent Health Allegations: Ardent Health faces accusations from July 18, 2024, to November 12, 2025, of inaccurately assessing the collectability of accounts receivable, leading to significant misrepresentation of its financial health, with investors required to act by March 9, 2026.
- CoreWeave Risk Disclosure: CoreWeave is alleged to have overstated its ability to meet customer demand during the period from March 28, 2025, to December 15, 2025, failing to adequately disclose the risks associated with reliance on a single third-party data center, which could materially impact revenue, with a lead plaintiff deadline of March 13, 2026.
- Bath & Body Works Financial Misrepresentation: Bath & Body Works is accused of failing to meet its financial guidance during the period from June 4, 2024, to November 19, 2025, with its brand collaboration strategy not effectively growing its customer base, requiring investor action by March 16, 2026.
See More
Varonis Systems Faces Securities Class Action Lawsuit
- Lawsuit Background: Varonis Systems, Inc. (NASDAQ: VRNS) is facing a securities class action lawsuit due to alleged material misstatements during the period from February 4, 2025, to October 28, 2025, with affected investors seeking recovery for their investment losses, highlighting potential deficiencies in the company's transparency and compliance.
- Investor Impact: The lawsuit targets investors who purchased or acquired Varonis common stock during the specified period, indicating that the company may have failed to sustain its annual recurring revenue (ARR) growth trajectory, which could lead to diminished investor confidence and negatively affect stock performance.
- Legal Process: The lead plaintiff deadline is set for March 9, 2026, allowing investors the option to become lead plaintiffs in the class action or to remain absent class members, a process that may influence the litigation's progress and outcomes, reflecting the proactive role of investors in legal recourse.
- Law Firm's Role: Kessler Topaz Meltzer & Check, LLP, as the representing law firm, specializes in securities fraud class actions, indicating its expertise and influence in investor protection, potentially providing crucial legal support for affected investors.
See More
Reminder for Varonis Investors on Class Action Deadline
- Earnings Miss: Varonis reported third-quarter 2025 results that missed expectations, with a 63.9% year-over-year decline in annual subscription revenues, indicating significant challenges in maintaining ARR growth, which could undermine investor confidence moving forward.
- Stock Plunge: Following the disappointing earnings report, Varonis's stock price plummeted by $30.66, or 48.7%, closing at $32.34 per share on October 29, 2025, resulting in substantial losses for investors and reflecting a pessimistic outlook on the company's future.
- Lawsuit Allegations: The class action lawsuit alleges that Varonis failed to disclose material adverse facts regarding its business and prospects during the class period, particularly its inability to sustain ARR growth, which may have misled investors about the company's true performance.
- Legal Action Deadline: Investors must file a lead plaintiff motion by March 9, 2026, to participate in the class action; those who do not act will automatically become absent members, potentially affecting their rights to recover losses.
See More
Reminder of Shareholder Class Action Lawsuits
- Fermi Inc. Lawsuit: The shareholder class action lawsuit against Fermi Inc. alleges that the company failed to disclose significant facts regarding tenant demand for its Project Matador campus between October 1 and December 11, 2025, leading to substantial investor losses, with a deadline of March 6, 2026, to apply as lead plaintiff.
- Ardent Health Case: The class action lawsuit against Ardent Health, Inc. claims that the company did not disclose material facts about the collectability of its accounts receivable from July 18, 2024, to November 12, 2025, and investors must apply by March 9, 2026, if they suffered losses during this period.
- Varonis Systems Lawsuit: The lawsuit against Varonis Systems, Inc. alleges that the company misled investors regarding its ability to convert its customer base and its ARR growth potential from February 4 to October 28, 2025, with a lead plaintiff application deadline of March 9, 2026.
- Law Firm Background: Holzer & Holzer, LLC, rated as a top securities litigation firm by ISS from 2021 to 2025, has been representing shareholders since 2000, recovering hundreds of millions for those affected by corporate misconduct.
See More
Varonis Systems Class Action Lawsuit Announcement
- Class Action Initiation: Robbins Geller law firm announces that investors who purchased Varonis Systems (NASDAQ: VRNS) common stock between February 4, 2025, and October 28, 2025, can apply to be lead plaintiff in the class action lawsuit by March 9, 2026, indicating strong investor concern over the company's financial transparency.
- Allegations: The lawsuit accuses Varonis and its executives of violating the Securities Exchange Act of 1934 by misleading investors regarding financial projections, failing to accurately reflect the sustainability of annual recurring revenue growth, which could lead to significant investor losses.
- Stock Price Plunge: Following the release of third-quarter results on October 28, 2025, which fell well below expectations, Varonis's stock price dropped nearly 49%, reflecting a severe lack of market confidence in the company's future growth potential, potentially impacting its financing capabilities and market position.
- Law Firm Background: Robbins Geller is one of the world's leading complex class action firms, recovering over $916 million for investors in 2025, showcasing its strong capabilities in securities fraud and shareholder rights litigation, which may attract more investors to participate in the lawsuit seeking compensation.
See More
Varonis Systems Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Varonis Systems (NASDAQ: VRNS) common stock between February 4, 2025, and October 28, 2025, to apply as lead plaintiffs by March 9, 2026, to participate in the class action without any out-of-pocket fees.
- Lawsuit Background: The lawsuit alleges that Varonis failed to maintain annual recurring revenue (ARR) projections and could not effectively convince existing customers to transition to the software-as-a-service (SaaS) model, resulting in significantly reduced ARR growth potential and investor losses.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and recovered over $438 million for investors in 2019 alone, being ranked No. 1 by ISS Securities Class Action Services in 2017, showcasing its strong capabilities in this field.
- Investor Guidance: Investors are advised to carefully select counsel with a proven track record to ensure effective representation in the class action, avoiding firms that merely act as intermediaries.
See More
Multiple Companies Face Class Action Lawsuits
- Varonis Systems Lawsuit: During the class period from February 4, 2025, to October 28, 2025, Varonis is accused of failing to sustain its annual recurring revenue growth, which has severely undermined investor confidence in the company's prospects, with a lead plaintiff deadline set for March 9, 2026.
- Ardent Health Allegations: Ardent Health faces accusations from July 18, 2024, to November 12, 2025, of inaccurately assessing the collectability of accounts receivable, leading to significant misrepresentation of its financial health, with investors required to act by March 9, 2026.
- CoreWeave Risk Disclosure: CoreWeave is alleged to have overstated its ability to meet customer demand during the period from March 28, 2025, to December 15, 2025, failing to adequately disclose the risks associated with reliance on a single third-party data center, which could materially impact revenue, with a lead plaintiff deadline of March 13, 2026.
- Bath & Body Works Financial Misrepresentation: Bath & Body Works is accused of failing to meet its financial guidance during the period from June 4, 2024, to November 19, 2025, with its brand collaboration strategy not effectively growing its customer base, requiring investor action by March 16, 2026.
See More
Varonis Systems Faces Securities Class Action Lawsuit
- Lawsuit Background: Varonis Systems, Inc. (NASDAQ: VRNS) is facing a securities class action lawsuit due to alleged material misstatements during the period from February 4, 2025, to October 28, 2025, with affected investors seeking recovery for their investment losses, highlighting potential deficiencies in the company's transparency and compliance.
- Investor Impact: The lawsuit targets investors who purchased or acquired Varonis common stock during the specified period, indicating that the company may have failed to sustain its annual recurring revenue (ARR) growth trajectory, which could lead to diminished investor confidence and negatively affect stock performance.
- Legal Process: The lead plaintiff deadline is set for March 9, 2026, allowing investors the option to become lead plaintiffs in the class action or to remain absent class members, a process that may influence the litigation's progress and outcomes, reflecting the proactive role of investors in legal recourse.
- Law Firm's Role: Kessler Topaz Meltzer & Check, LLP, as the representing law firm, specializes in securities fraud class actions, indicating its expertise and influence in investor protection, potentially providing crucial legal support for affected investors.
See More
